Sort
59,101 grants matching “hypertension”
Targeting smooth muscle cell BMAL1 as a new therapeutic strategy against restenosis
$664,969Zhenheng Guo · University Of Kentucky · R01 · FY2023 · HL
Targeting smooth muscle cell BMAL1 as a new therapeutic strategy against restenosis
$664,969Zhenheng Guo · University Of Kentucky · R01 · FY2025 · HL
Genetic Determinants of Thoracic Aortic Aneurysms and Dissection
$664,933Xing-Li Wang · University Of Texas Hlth Sci Ctr Houston · P50 · FY2009 · HL
Kidney Donor Outcomes Cohort (KDOC) Study
$664,830James R Rodrigue · Beth Israel Deaconess Medical Center · R01 · FY2012 · DK
Weight Loss in Primary Care: A Translation of the Diabetes Prevention Program
$664,815Ruth S Weinstock · Upstate Medical University · R18 · FY2009 · DK
Preterm birth and long-term risk of cardiovascular disease in mothers and offspring
$664,798Casey Crump · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · HL
Preterm birth and long-term risk of cardiovascular disease in mothers and offspring
$664,798Casey Crump · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · HL
Preterm birth and long-term risk of cardiovascular disease in mothers and offspring
$664,798Casey Crump · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · HL
Pathogenesis of renal injury and hypertension in HIV+ children
$664,746Patricio Ernesto Ray · University Of Virginia · R01 · FY2025 · DK
Activity Levels, Myosteatosis and Insulin Resistance/Diabetes Mellitus
$664,700Matthew A Allison · University Of California, San Diego · R01 · FY2023 · HL
Targeting the Arrhythmogenic Sources of Human Atrial Fibrillation
$664,678Vadim V Fedorov · Ohio State University · R01 · FY2020 · HL
Targeting the Arrhythmogenic Sources of Human Atrial Fibrillation
$664,678Vadim V Fedorov · Ohio State University · R01 · FY2019 · HL
Informing alcohol policy: The impact of evidence-based alcohol warnings on consumption
$664,633Marissa Hall · Univ Of North Carolina Chapel Hill · R01 · FY2025 · AA
Individualizing pharmacotherapy: A novel optimization strategy to increase smoking cessation in the African American community.
$664,624Nicole L Nollen · University Of Kansas Medical Center · R01 · FY2021 · DA
A Phase II Trial of Metformin for Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction
$664,604Marc A Simon · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · AG
A Phase II Trial of Metformin for Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction
$664,604Marc A Simon · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · AG
Tailored Case Management for Diabetes and Hypertension
$664,508David Edelman · Duke University · R01 · FY2008 · DK
Engineering a novel biomaterial for oxygen transport applications
$664,429Andre Francis Palmer · Ohio State University · R01 · FY2021 · HL
Quantitation of Factors Regulating Glucose Tolerance
$664,351Richard N. Bergman · Cedars-Sinai Medical Center · R01 · FY2016 · DK
Genotypic and functional properties of HIV-1 Nef clinical isolates in PAH-HIV
$664,323Sonia Castro Flores · University Of Colorado Denver · U01 · FY2013 · HL
Vascular Stiffness and Pulmonary Congestion
$664,313William Gregory Hundley · Wake Forest University Health Sciences · R01 · FY2007 · HL
Interactive Multirisk-factor Intervention for HTN Blacks
$664,303Boston Medical Center · R01 · FY2003 · HL
Kidney Tubular Damage and Dysfunction Identify a Novel Axis of Chronic Kidney Disease
$664,281Joachim H Ix · Veterans Medical Research Fdn/San Diego · R01 · FY2020 · DK
Mitochondrial dysfunction in pulmonary hypertension
$664,270Olga Rafikova · Indiana University Indianapolis · R01 · FY2024 · HL
KLF4-Dependent Regulation of SMC Differentiation and Phenotypic Switching
$664,239Gary K Owens · University Of Virginia · R01 · FY2010 · HL